# BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE
> **ANDA075231** · Abbreviated New Drug Application (Generic) · Sponsor: LGM PHARMA · Approved 2001-11-30
## Drug
- **FDA Application Number:** ANDA075231
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE
- **Generic name:** BUTALBITAL, ASPIRIN, CAFEINE, AND CODEINE PHOSPHATE
- **Active ingredients:** ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** LGM PHARMA
- **Manufacturer:** LGM PHARMA SOLUTIONS, LLC
- **First approval:** 2001-11-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075231)
---
*AI Analytics · CC0 1.0*